Control Bionics (ASX:CBL) Other Current Liabilities: A$0.24 Mil (As of Dec. 2025)


What is Control Bionics Other Current Liabilities?

Control Bionics ASX:CBL Other Current Liabilities is A$0.24 Mil as of Dec. 2025. The stock has 4 warning signs investors should review.

Control Bionics's other current liabilities for the quarter that ended in Dec. 2025 was A$0.24 Mil.

Control Bionics's quarterly other current liabilities increased from Dec. 2024 (A$0.22 Mil) to Jun. 2025 (A$0.24 Mil) but then declined from Jun. 2025 (A$0.24 Mil) to Dec. 2025 (A$0.24 Mil).

Control Bionics's annual other current liabilities declined from Jun. 2023 (A$0.23 Mil) to Jun. 2024 (A$0.21 Mil) but then increased from Jun. 2024 (A$0.21 Mil) to Jun. 2025 (A$0.24 Mil).

Control Bionics Other Current Liabilities Related Terms

Control Bionics Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Control Bionics's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Control Bionics Other Current Liabilities Chart

Control Bionics Annual Data
Trend Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Other Current Liabilities
Get a 7-Day Free Trial 0.29 0.35 0.23 0.21 0.24

Control Bionics Semi-Annual Data
Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.15 0.21 0.22 0.24 0.24

Control Bionics Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of A$0.24 Mil mean?
Control Bionics (ASX:CBL) has a Other Current Liabilities of A$0.24 Mil as of Dec. 2025. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Control Bionics.
Is Control Bionics' Other Current Liabilities too high?
Control Bionics' current Other Current Liabilities is A$0.24 Mil.
How does Control Bionics' Other Current Liabilities compare to ABT and SYK?
Control Bionics' Other Current Liabilities of A$0.24 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Medical Devices & Instruments company?
A good Other Current Liabilities depends on the Medical Devices & Instruments industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Control Bionics. Control Bionics's current Other Current Liabilities is A$0.24 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Control Bionics stock overvalued right now?
Based on GuruFocus' analysis, Control Bionics (ASX:CBL) is currently considered Significantly Overvalued. The stock's GF Value™ is A$0.03, compared to a current price of A$0.08 — trading 150% above its estimated fair value. The current Other Current Liabilities is A$0.24 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Control Bionics (ASX:CBL), the current Other Current Liabilities is A$0.24 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Control Bionics Business Description

Address 11-13 Pearson Street, Level 4, Cremorne, VIC, AUS, 3121
Control Bionics Ltd is engaged in the healthcare device business. It is involved in developing, commercializing, and selling assistive communications technology systems within the disability sector. Its core systems include NeuroNode Trilogy and NeuroNode3. These systems allow people with speech and movement difficulties to control a computer for speech generation, electronic communications, entertainment, and external control of other devices. Geographically, it derives a majority of revenue from North America and has its presence in Australia as well.